Efficacy and Safety of Glycaemic Control of Levemir [insulin detemir] or Insulatard [insulin suspension isophane] in Patients With Type 2 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 28 Nov 2016
At a glance
- Drugs Insulin detemir (Primary) ; Insulin suspension isophane (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 26 Jun 2012 Additional lead trial investigator (Beril Tom-de Vries) identified as reported by ClinicalTrials.gov.
- 16 Oct 2009 Actual patient number (342) added as reported by ClinicalTrials.gov.